受强制性开放获取政策约束的文章 - Nicolas Bery了解详情
无法在其他位置公开访问的文章：1 篇
Single domain antibodies with VH hallmarks are positively selected during panning of llama (Lama glama) naïve libraries
A Monegal, A Olichon, N Bery, T Filleron, G Favre, A de Marco
Developmental & Comparative Immunology 36 (1), 150-156, 2012
强制性开放获取政策： German Research Foundation, National Institute of Health and Medical …
可在其他位置公开访问的文章：22 篇
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
S Moutel, N Bery, V Bernard, L Keller, E Lemesre, A De Marco, L Ligat, ...
Elife 5, e16228, 2016
强制性开放获取政策： National Institute of Health and Medical Research, France
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds
A Cruz-Migoni, P Canning, CE Quevedo, CJR Bataille, N Bery, A Miller, ...
Proceedings of the National Academy of Sciences 116 (7), 2545-2550, 2019
强制性开放获取政策： Blood Cancer UK, UK Engineering and Physical Sciences Research Council, UK …
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
CE Quevedo, A Cruz-Migoni, N Bery, A Miller, T Tanaka, D Petch, ...
Nature communications 9 (1), 3169, 2018
强制性开放获取政策： UK Biotechnology and Biological Sciences Research Council, Blood Cancer UK …
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
N Bery, A Miller, T Rabbitts
Nature Communications 11 (1), 3233, 2020
强制性开放获取政策： Blood Cancer UK, UK Medical Research Council, Wellcome Trust
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
S Guillard, P Kolasinska-Zwierz, J Debreczeni, J Breed, J Zhang, N Bery, ...
Nature communications 8 (1), 16111, 2017
强制性开放获取政策： UK Medical Research Council, Wellcome Trust
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe
N Bery, S Legg, J Debreczeni, J Breed, K Embrey, C Stubbs, ...
Nature Communications 10 (1), 2607, 2019
强制性开放获取政策： UK Medical Research Council, Wellcome Trust
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
N Bery, A Cruz-Migoni, CJR Bataille, CE Quevedo, H Tulmin, A Miller, ...
Elife 7, e37122, 2018
强制性开放获取政策： Blood Cancer UK, UK Medical Research Council, Wellcome Trust
RNase H2, mutated in Aicardi‐Goutières syndrome, resolves co-transcriptional R-loops to prevent DNA breaks and inflammation
A Cristini, M Tellier, F Constantinescu, C Accalai, LO Albulescu, ...
Nature communications 13 (1), 2961, 2022
强制性开放获取政策： UK Medical Research Council, Wellcome Trust, UK Research & Innovation, Royal …
Selection and characterization of a nanobody biosensor of GTP-bound RHO activities
L Keller, N Bery, C Tardy, L Ligat, G Favre, TH Rabbitts, A Olichon
Antibodies 8 (1), 8, 2019
强制性开放获取政策： UK Medical Research Council, Wellcome Trust
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model
H Pais, K Ruggero, J Zhang, O Al-Assar, N Bery, R Bhuller, V Weston, ...
Scientific Reports 9 (1), 5760, 2019
强制性开放获取政策： Cancer Research UK, UK Engineering and Physical Sciences Research Council …
Bioluminescence Resonance Energy Transfer 2 (BRET2)‐based RAS biosensors to characterize RAS inhibitors
N Bery, TH Rabbitts
Current Protocols in Cell Biology 83 (1), e83, 2019
强制性开放获取政策： UK Medical Research Council, Wellcome Trust
A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2
N Bery, CJR Bataille, A Russell, A Hayes, F Raynaud, S Milhas, S Anand, ...
Science Advances 7 (15), eabg1950, 2021
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, UK Medical Research Council, Wellcome Trust
Cytidine deaminase resolves replicative stress and protects pancreatic cancer from DNA-targeting drugs
A Lumeau, N Bery, A Frances, M Gayral, G Labrousse, C Ribeyre, ...
Cancer Research 84 (7), 1013-1028, 2024
强制性开放获取政策： National Institute of Health and Medical Research, France, Swiss Cancer League
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
P Canning, C Bataille, N Bery, S Milhas, A Hayes, F Raynaud, A Miller, ...
Journal of Immunological Methods 494, 113051, 2021
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, UK Medical Research Council, Wellcome Trust
TDP1 mutation causing SCAN1 neurodegenerative syndrome hampers the repair of transcriptional DNA double-strand breaks
M Geraud, A Cristini, S Salimbeni, N Bery, V Jouffret, M Russo, AC Ajello, ...
Cell Reports 43 (5), 2024
强制性开放获取政策： National Institute of Health and Medical Research, France
Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders
A Cornebois, M Sorbara, M Cristol, E Vigne, P Cordelier, K Desrumeaux, ...
Iscience 27 (5), 2024
强制性开放获取政策： National Institute of Health and Medical Research, France
Cytidine deaminase protects pancreatic cancer cells from replicative stress and drives resistance to DNA-targeting drugs
A Lumeau, N Bery, A Francès, M Gayral, C Ribeyre, C Lopez, A Névot, ...
bioRxiv, 2021.10. 23.465566, 2021
强制性开放获取政策： National Institute of Health and Medical Research, France
A cell-based screening method using an intracellular antibody for discovering small molecules targeting hard-to-drug proteins
N Bery, TH Rabbitts
Bio-protocol 12 (4), e4324-e4324, 2022
强制性开放获取政策： Blood Cancer UK
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies
S Figarol, C Delahaye, R Gence, A Doussine, JP Cerapio, M Brachais, ...
Nature Communications 15 (1), 5345, 2024
强制性开放获取政策： National Institute of Health and Medical Research, France, Swiss Cancer League
出版信息和资助信息由计算机程序自动确定